Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-02-21 @ 9:06 PM
Study NCT ID:
NCT05566756
Status:
COMPLETED
Last Update Posted:
2025-08-27
First Post:
2022-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-30
First Submit QC Date:
None
Study First Post Date:
2022-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-26
Last Update Post Date:
2025-08-27
Last Update Post Date Type:
ESTIMATED